QR-koodi

Inhibition of topoisomerase II by ICRF-193 prevents efficient replication of herpes simplex virus type 1.

Cellular topoisomerase II is specifically inactivated by the drug ICRF-193. This compound turns topoisomerase II into a closed clamp that is unable to cleave DNA. We have investigated the effects of this inhibitor on the replication of herpes simplex virus type 1. We show that ICRF-193 at low multip...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Virol
Päätekijät: Hammarsten, O, Yao, X, Elias, P
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 1996
Aiheet:
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190388/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8676478/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.70.7.4523-4529.1996
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!